Issue Price
₹96
Per Share
GMP
NIL
Grey Market
Est. Listing
₹96
Expected Price
Min. Application
₹230,400
2 lots × 1200 shares
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.As of May 31, 2024, the company employed 85 people in various departments.
Clinitech Laboratory Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 31,200 | — | ₹0.30 Cr | — |
| TOTAL | 602,400 | 100.00% | ₹5.78 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹115,200 |
| Retail (Max) | 13 | 15,600 | ₹1,497,600 |
| sNII (Min) | 14 | 16,800 | ₹1,612,800 |
| bNII (Min) | 68 | 81,600 | ₹7,833,600 |
| Particulars | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue from Operations | 643.92 | 636.34 | 645.70 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 37.12 | 61.31 | 51.26 |
| Net Worth | 354.80 | 238.08 | 184.81 |
| Total Assets | 560.79 | 603.33 | 368.74 |
| Reserves & Surplus | 186.80 | 88.08 | 34.81 |
| Total Borrowings | 86.31 | 102.91 | 88.61 |